Cramer says traders promoting journey shares after J&J Covid vaccine pause are mistaken


Jim Cramer

Scott Mlyn | CNBC

CNBC’s Jim Cramer stated Tuesday he was not involved concerning the inventory market impression stemming from U.S. regulators recommending a pause in using Johnson & Johnson‘s one-shot Covid vaccine.

U.S. inventory futures turned lower in a sudden move earlier Tuesday after the Meals and Drug Administration asked states to temporarily stop administering J&J’s vaccine whereas it investigates reported circumstances of blood clotting. Futures shed a number of the losses, nonetheless, after the stronger-than-expected March inflation report was released.

“I do not suppose that is actually going to impression the market practically as a lot because it indicated” within the premarket, the “Mad Money” host stated, referring to the J&J vaccine pause. “I do not count on this to impression journey and leisure in any respect. I believe people who find themselves promoting these shares are mistaken.”